GPHC launches probe after two young cancer patients die after medication was administered

In a statement last evening, the hospital’s administration the investigation involves the interviewing of all medical persons directly involved along with an assessment of the medication administered.  

GPHC launches probe after two young cancer patients die after medication was administered

The Georgetown Public Hospital has announced that it has launched an investigation into the adverse reaction of a number of children who were cancer patients, to a particular medication that was administered to them.

There are reports that two of the children died from complications after the medication was reportedly administered to them.

The affected children were all cancer patients in the hospital’s pediatric ward.

In a statement last evening, the hospital’s administration the investigation involves the interviewing of all medical persons directly involved along with an assessment of the medication administered.

The Hospital said the usage of the particular medication, which it did not name, has been discontinued.

According to the hospital, while the investigation continues it would advise members of the public “to resist the urge to speculate on what is a sensitive matter and to await the findings of the investigation”.

The hospital said it is working closely with all stakeholders, including the Ministry of Public Health, the Pan American Health Organization, World Health Organisation and other agencies in an effort to improve its services.

It has expressed sincerest condolences to the parents of the young cancer patients who died, adding that it will provide full answers upon the completion of the investigation.

 

You must be logged in to post a comment Login